Best Immunotherapy Doctors Worldwide — TOP 106

Chief physician and professor. Grade 1 Expert at the Cancer Center, West China Hospital, Sichuan University (ranked No. 2 in China). Completed a postdoctoral fellowship in interventional radiology at the Chinese PLA General Hospital. Leads multidisciplinary team (MDT) care for complex tumors. Expert in minimally invasive interventional oncology for liver, lung, and pancreatic cancers.

Accreditations: Council Member, WATA. Member of CACA and CMDA committees on intervention, ablation, radioactive seeds, and pain. In 2023, inaugural director member, Palliative Care Committee, Sichuan MDA. Editorial board member of the Chinese Journal of Interventional Imaging and Therapy. Editorial board member of the Chinese Journal of Pain Medicine.

Leads 2 provincial S&T projects and 2 NSFC projects. Has 40+ papers, with 30+ as first or corresponding author. Highest impact factor: 10.73. Hepatocellular carcinoma (HCC) cohort: TACE + lenvatinib vs TACE + sorafenib. OS 18.97 vs 10.77 months. PFS 10.6 vs 5.4 months. ORR 66.8% vs 33.3%.

Dr. Bülent Karagöz specializes in tumor immunology and cancer immunotherapy with over 33 years of experience of experience. He leads the Medical Oncology Department at Anadolu Medical Center.

• Professor at Istanbul Okan University Faculty of Medicine
• Author of 40+ publications in cancer research
• Member of the Turkish Medical Oncology Association
• Expert in targeted therapies for sarcoma, lymphoma, and pancreatic cancer

Dr. Zafer Gulbas founded and directs Turkey’s largest Bone Marrow Transplant Center at Anadolu Medical Center. He is a hematologist-oncologist specializing in complex blood cancers and clotting disorders. Dr. Gulbas trained at top global institutions, including MD Anderson and Fred Hutchinson in the USA. He performs autologous and allogeneic transplants for leukemia, lymphoma, and aplastic anemia.

• Achieved an 81% success rate for autologous bone marrow transplants.
• Supervised over 3,000 successful transplant procedures since 2010.
• Authored over 260 scientific publications with 5,000+ citations in hematology.
• Member of the European Hematology Association and American Hematology Association.

Dr. Mustafa Solak specializes in immunotherapy for various cancers at Hisar Hospital Intercontinental, trained at top institutions like Hacettepe University and MD Anderson Cancer Center.

• Fellowship-trained in oncology at Hacettepe University Cancer Institute
• Handled numerous cases of breast, lung, and gastrointestinal cancers
• Worked at The University of Texas MD Anderson Cancer Center

Leading immunotherapy trials at Sourasky Medical Center – Dr. Raphael specializes in genomic profiling and intra-tumoral injections for thoracic cancers.

• Principal investigator for multiple immunotherapy clinical trials, including pembrolizumab studies
• Expert in liquid biopsies and T-cell repertoire sequencing for treatment response
• Molecular Tumor Board moderator for the Israeli Lung Cancer Society
• Honored as Outstanding Teacher at Tel-Aviv University's medical faculty
• Fellowship-trained in Innovation and Entrepreneurship in Medicine and Health-Tech

Professor Ralf Buhl is a leading neurosurgeon specializing in brain metastasis surgery and intracranial cavernomas treatment, actively contributing to scientific research.

• Author of 47+ scientific papers on neuropathology
• Co-founder of a Fund devoted to brain tumor research
• Expert in neuronavigation and minimally invasive techniques
• Practices at Medical Center in Solingen

Prof. Christoph Zielinski is a global leader in immunotherapy with 44 years of experience shaping modern cancer care. He integrates cutting-edge research with personalized patient treatments.

• Founded Vienna's Comprehensive Cancer Center (CCC) – unifying research and clinical care
• Headed Austria's largest oncology department at Vienna General Hospital
• Former President of the Central European Cooperative Oncology Group (CECOG)
• Specializes in tumor biology-driven individualized cancer therapies

Dr. Pelles Sharon specializes in immunotherapy, including treatments like Keytruda, at Sourasky Medical Center (Ichilov).

• Experienced in various cancer treatments with a focus on immunotherapy
• Contributed to clinical research on oncologic patients' attitudes towards trials
• Performs advanced procedures like Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
• Offers targeted therapies alongside traditional cancer treatments

Prof. Merimsky leads immunotherapy research at Sourasky Medical Center, with decades of expertise in advanced cancer treatments.

• Head of the Unit for Soft Tissue and Bone Oncology
• Faculty member at European Society of Medical Oncology (ESMO) Sarcoma group
• Extensive research collaborations with Weizmann Institute and Felsenstein Medical Research Center
• Over 41 years of experience' experience in clinical oncology practice

Dr. Sarid, a senior oncologist at Ichilov, specializes in biological cancer therapy with over 30 published articles on cancer treatments.

• Over 38 years of experience as a senior oncologist at Sourasky Medical Center
• Principal investigator in clinical trials for cancer therapies
• Specialty training in cancer urology from Oxford University
• Member of ESMO and ASCO – leading oncology organizations

Specialist in Oncological Gynecology and Radiotherapy – Dr. Sapra brings focused expertise to immunotherapy cases at Sourasky Medical Center.

• Specializes in gynecological oncology treatments
• Expertise in radiotherapy applications
• Practices at a leading medical center in Israel

Dr. Manuela Seifert leads the Breast Cancer Center at Solingen Clinic, specializing in breast-sparing surgeries and aesthetic reconstruction.

• Over 26 years of experience of experience in gynecology and breast cancer treatment
• Expert in breast-sparing techniques and plastic reconstruction
• Head of the Breast Cancer Center at Solingen Clinic
• Provides comprehensive and personalized care for each patient

Dr. Onder Surgit is a professor of general surgery at Optimed International Hospital. He is a surgical instructor at the Advanced Medical Technologies Training Center (ITEM). Dr. Surgit treats cancer, obesity, and complex gastrointestinal conditions. He applies laparoscopic techniques for weight loss and tumor removal.

• Specializes in bariatric surgery including gastric sleeve, bypass, and balloon procedures.
• Performs oncological surgeries for breast, lung, stomach, and colon cancer.
• Served as a faculty member at Turgut Ozal and Atilim Universities.
• Works at AACI-accredited Optimed International Hospital in Tekirdag, Turkey.

Dr. Hana Golan heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation Division at Sheba Medical Center. She specializes in high-risk pediatric tumors and complex childhood cancers. Dr. Golan serves as the principal investigator for the High-Risk Neuroblastoma ESIOP protocol. She practices at a hospital ranked among the global top 10 by Newsweek.

• National coordinator of multicenter oncology protocols and international Phase I/II clinical trials.
• Performs bone marrow transplants and CAR T-cell therapy for pediatric patients.
• Expert in neuroblastoma, leukemia, and treatment-resistant malignancies.
• Senior Lecturer at the Sackler Faculty of Medicine at Tel Aviv University.

Prof. Sezer Sağlam specializes in immunotherapy at Gayrettepe Florence Nightingale Hospital, with extensive experience in gastrointestinal oncology.

• Professor of Medical Oncology since 2016
• Fellowship-trained at Istanbul University Medical Faculty
• Member of ESMO, ASCO, and ENET
• Attending physician in Gastrointestinal Oncology

Professor Luo Xiaoping is a nationally recognized interventional radiologist and a leading authority in Western China. He began pioneering vascular interventions in the early 1990s. He helped found the Interventional Group at the Second Affiliated Hospital of Chongqing Medical University.

He has completed over 100,000 interventional procedures, including about 4,000 complex cases. His key skills include TACE for hepatocellular carcinoma, Budd–Chiari interventions, TIPS, and single-stage bilateral stenting for hilar biliary obstruction, with success rates near 100%. He has been a master’s supervisor since 2007. He has trained many physicians, guided complex cases at more than 40 major hospitals across Western China, and helped build interventional programs. He has published 32 papers as first or corresponding author (22 CSCD core, 4 Chinese core, 6 CSCD extended).

Dr. He Weibing is a pioneer of argon-helium cryoablation in China with more than 20 years of frontline practice. He was a founding member of Fuda Cancer Hospital (Guangzhou). He co-founded its Minimally Invasive Tumor Treatment Center and served as Executive Deputy Director. He also helped found the Ablation Group of the China Anti-Cancer Association. He has been the primary operator in more than 10,000 procedures.

He specializes in tumor cryoablation and is proficient in 125I seed brachytherapy, with a focus on liver and lung cancers. He proposed ten argon-helium techniques. Key co-authored data include: lung cryotherapy n=508; NSCLC n=120 (CR 25.5%, PR 41.8%, 6/12/24-month survival 64%/55%/36%); pancreatic cancer n=38 (median survival 12 months). He served on editorial boards in 2008 and 2010. He has been a national trainer for Varian and Boston Scientific since 2001.

Prof. Amit Tirosh leads the Neuroendocrine Tumors Service at Sheba Medical Center, specializing in complex hereditary syndromes.

• Expert in Peptide Receptor Radionuclide Therapy (PRRT)
• Head of the Endocrine Oncology Bioinformatics Laboratory
• Affiliated with NIH for MEN1 syndrome research
• Author of 40+ publications on neuroendocrine tumors
• Part of international expert panels on VHL disease

Dr. Yuri Goldes is the Deputy Director of General Surgery at Sheba Medical Center. He pioneered some of Israel’s first robotic resections for stomach and pancreatic cancers. Forbes Israel named him among the nation’s best gastrointestinal surgeons. In 2019, he received the Best Doctor of the Year award from the Israeli Ministry of Health.

• Specializes in robotic and laparoscopic surgery for pancreatic, gastric, and esophageal cancers.
• Performs minimally invasive Whipple procedures, one of the most complex abdominal operations.
• Treats benign conditions including diaphragmatic hernia, achalasia, GERD, and gallbladder disease.
• Works at Sheba Medical Center, ranked among the Top 10 hospitals worldwide by Newsweek.

Dr. Graupera heads the Hematology Oncology Department at Sant Joan De Déu – one of Europe's top children's hospitals. His research focuses on pediatric cancer treatments.

• Trained at Memorial Sloan Kettering Cancer Center in the USA
• Developed a radiation-free treatment for spinal cord gliomas
• Recipient of multiple prestigious oncology awards
• Published 70+ papers on pediatric cancer treatments